Free Trial
NYSE:BIO.B

Bio-Rad Laboratories (BIO.B) Stock Price, News & Analysis

Bio-Rad Laboratories logo
$334.85 0.00 (0.00%)
(As of 11/15/2024 ET)

About Bio-Rad Laboratories Stock (NYSE:BIO.B)

Key Stats

Today's Range
$334.85
$334.85
50-Day Range
$326.74
$373.35
52-Week Range
$271.00
$352.91
Volume
8 shs
Average Volume
26 shs
Market Capitalization
$9.38 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Receive BIO.B Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter.

BIO.B Stock News Headlines

Wells Fargo Remains a Hold on Bio-Rad Laboratories (BIO)
Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
Bio-Rad Laboratories Reports Q3 2024 Earnings Growth
See More Headlines

BIO.B Stock Analysis - Frequently Asked Questions

Bio-Rad Laboratories' stock was trading at $320.65 at the beginning of the year. Since then, BIO.B stock has increased by 4.4% and is now trading at $334.85.
View the best growth stocks for 2024 here
.

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) posted its earnings results on Thursday, August, 1st. The company reported $3.11 earnings per share for the quarter. The company had revenue of $638.48 million for the quarter. Bio-Rad Laboratories had a negative net margin of 30.18% and a positive trailing twelve-month return on equity of 3.74%.

Bio-Rad Laboratories subsidiaries include Celsee, Raindance Technologies Limited, GnuBIO Inc., Bio-Rad AbD Serotec GmbH, QuantaLife, DiaMed Holding AG, Blackhawk Biosystems, and more.

Shares of BIO.B stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Last Earnings
8/01/2024
Today
11/17/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/20/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NYSE:BIO.B
Employees
8,200
Year Founded
1952

Profitability

Net Income
$-637,320,000.00
Pretax Margin
-38.96%

Debt

Sales & Book Value

Annual Sales
$2.58 billion
Cash Flow
$12.11 per share
Book Value
$267.45 per share

Miscellaneous

Free Float
20,051,000
Market Cap
$9.55 billion
Optionable
Not Optionable
Beta
0.73

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (NYSE:BIO.B) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners